Cardiac expression and atrial fibrillation-associated remodeling of K 2P2.1 (TREK-1) K+ channels in a porcine model

Life Sciences

Volumn 97, Issue 2, 2014, Pages 107-115

  Schmidt, Constanze ^a   Wiedmann, Felix ^a   Tristram, Frank ^b   Anand, Priya ^b   Wenzel, Wolfgang ^b   Lugenbiel, Patrick ^a   Schweizer, Patrick A ^a   Katus, Hugo A ^a   Thomas, Dierk ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Atrial fibrillation; Background potassium current; Cardiac action potential; Electrical remodeling; K2P channel; Membrane potential

Indexed keywords

ATRIAL FIBRILLATION; BACKGROUND POTASSIUM CURRENT; CARDIAC ACTION POTENTIAL; ELECTRICAL REMODELING; K(2P) CHANNEL; MEMBRANE POTENTIAL;

ANIMALS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GLYCOSYLATION; HEART ATRIA; HUMANS; OOCYTES; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; REAL-TIME POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; SWINE; TIME FACTORS; XENOPUS LAEVIS;

EID: 84894043197     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.006     Document Type: Article

References (40)

1. A.S. Barth, S. Merk, E. Arnoldi, L. Zwermann, P. Kloos, and M. Gebauer et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature Circ Res 96 2005 1022 1029
2. O. Bikou, D. Thomas, K. Trappe, P. Lugenbiel, K. Kelemen, and M. Koch et al. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model Cardiovasc Res 92 2011 218 225
3. + ion channel Science 335 2012 436 441
4. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 2008 802 809
5. T.J. Cha, J.R. Ehrlich, L. Zhang, and S. Nattel Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure Circulation 110 2004 1520 1526
6. I.E. Christophersen, M.S. Olesen, B. Liang, M.N. Andersen, A.P. Larsen, and J.B. Nielsen et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation Eur Heart J 34 2013 1517 1525
7. N. Decher, K. Wemhöner, S. Rinné, M.F. Netter, M. Zuzarte, and M.I. Aller et al. Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex Cell Physiol Biochem 28 2011 77 86
8. B.C. Donner, M. Schullenberg, N. Geduldig, A. Hüning, J. Mersmann, and K. Zacharowski et al. Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability Basic Res Cardiol 106 2011 75 87
9. P. Ellinghaus, R.J. Scheubel, D. Dobrev, U. Ravens, J. Holtz, and J. Huetter et al. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays J Thorac Cardiovasc Surg 129 2005 1383 1390
10. + channel EMBO J 15 1996 6854 6862
11. 2P) potassium leak channels by the tyrosine kinase inhibitor genistein Br J Pharmacol 154 2008 1680 1690
12. 2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone Naunyn Schmiedebergs Arch Pharmacol 381 2010 261 270
13. + channels Biochim Biophys Acta 1818 2012 33 41
14. S.A. Goldstein, D. Bockenhauer, I. O'Kelly, and N. Zilberberg Potassium leak channels and the KCNK family of two-P-domain subunits Nat Rev Neurosci 2 2001 175 184
15. + channels in the cardiovascular system: their significance and potential as a therapeutic target Cardiovasc Ther 30 2012 e23 e29
16. + channel β subunits Life Sci 91 2012 377 383
17. P. Lugenbiel, D. Thomas, K. Kelemen, K. Trappe, O. Bikou, and P.A. Schweizer et al. Genetic suppression of Gαs protein provides rate control in atrial fibrillation Basic Res Cardiol 107 2012 265
18. A.D. Medhurst, G. Rennie, C.G. Chapman, H. Meadows, M.D. Duckworth, and R.E. Kelsell et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery Brain Res Mol Brain Res 86 2001 101 114
19. A.N. Miller, and S.B. Long Crystal structure of the human two-pore domain potassium channel K2P1 Science 335 2012 432 436
20. S. Nattel, A. Maguy, S. Le Bouter, and Y.H. Yeh Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation Physiol Rev 87 2007 425 456
21. S. Nattel, B. Burstein, and D. Dobrev Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 1 2008 62 73
22. R.S. Oakes, T.J. Badger, E.G. Kholmovski, N. Akoum, N.S. Burgon, and E.N. Fish et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation Circulation 119 2009 1758 1767
23. + channels Br J Pharmacol 166 2012 764 773
24. U. Ravens Novel pharmacological approaches for antiarrhythmic therapy Naunyn Schmiedebergs Arch Pharmacol 381 2010 187 193
25. G. Sandoz, S.C. Bell, and E.Y. Isacoff Optical probing of a dynamic membrane interaction that regulates the TREK1 channel Proc Natl Acad Sci U S A 108 2011 2605 2610
26. C. Schmidt, J. Kisselbach, P.A. Schweizer, H.A. Katus, and D. Thomas The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation Vasc Health Risk Manag 7 2011 193 202
27. 2P) channels Naunyn Schmiedebergs Arch Pharmacol 385 2012 1003 1016
28. + (K2P) channels Eur J Pharmacol 721 2013 237 248
29. U. Schotten, S. Verheule, P. Kirchhof, and A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 2011 265 325
30. + current inhibition by endothelin-1 is mediated by Rho kinase-dependent channel phosphorylation Br J Pharmacol 165 2012 1467 1475
31. R. Soucek, D. Thomas, K. Kelemen, O. Bikou, C. Seyler, and F. Voss et al. Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant Heart Rhythm 9 2012 265 272
32. + channels J Physiol 589 2011 3709 3720
33. + leak channels Br J Pharmacol 163 2011 1099 1110
34. Xian Tao Li, V. Dyachenko, M. Zuzarte, C. Putzke, R. Preisig-Müller, and G. Isenberg et al. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle Cardiovasc Res 69 2006 86 97
35. C. Terrenoire, I. Lauritzen, F. Lesage, G. Romey, and M. Lazdunski A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics Circ Res 89 2001 336 342
36. 2P2.1 potassium channels permeable to sodium Neuron 58 2008 859 870
37. K. Trappe, D. Thomas, O. Bikou, K. Kelemen, P. Lugenbiel, and F. Voss et al. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study Eur Heart J 34 2013 147 157
38. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation Circ Res 80 1997 772 781
39. R. Wakili, N. Voigt, S. Kääb, D. Dobrev, and S. Nattel Recent advances in the molecular pathophysiology of atrial fibrillation J Clin Invest 121 2011 2955 2968
40. J.M. Wang, P. Cieplak, and P.A. Kollman How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21 2000 1049 1074